CELIA, Christian

CELIA, Christian  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery 1-gen-2020 Barone, A.; Cristiano, M. C.; Cilurzo, F.; Locatelli, M.; Iannotta, D.; Di Marzio, L.; Celia, C.; Paolino, D.
Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer 1-gen-2021 Di Francesco, M.; Celia, C.; Cristiano, M. C.; D'Avanzo, N.; Ruozi, B.; Mircioiu, C.; Cosco, D.; Di Marzio, L.; Fresta, M.
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 1-gen-2010 Paolino, D.; Cosco, D.; Racanicchi, L.; Trapasso, E.; Celia, C.; Iannone, M.; Puxeddu, E.; Costante, G.; Filetti, S.; Russo, D.; Fresta, M.
Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis 1-gen-2022 Bruno, Maria Chiara; Cristiano, Maria Chiara; Celia, Christian; D'Avanzo, Nicola; Mancuso, Antonia; Paolino, Donatella; Wolfram, Joy; Fresta, Massimo
LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy 1-gen-2021 D'Avanzo, N.; Torrieri, G.; Figueiredo, P.; Celia, C.; Paolino, D.; Correia, A.; Moslova, K.; Teesalu, T.; Fresta, M.; Santos, H. A.
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 1-gen-2008 Celia, C; Malara, N; Terracciano, R; Cosco, D; Paolino, D; Fresta, M; Savino, R
Multidrug Idebenone/Naproxen Co-loaded Aspasomes for Significant in vivo Anti-inflammatory Activity 1-gen-2022 D'Avanzo, N.; Cristiano, M. C.; Di Marzio, L.; Bruno, M. C.; Paolino, D.; Celia, C.; Fresta, M.
Nanoliposomes as Multidrug Carrier of Gemcitabine/Paclitaxel for the Effective Treatment of Metastatic Breast Cancer Disease: A Comparison with Gemzar and Taxol 1-gen-2021 Celia, C.; Cristiano, M. C.; Froiio, F.; Di Francesco, M.; D'Avanzo, N.; Di Marzio, L.; Fresta, M.
Nanonutraceuticals: The new frontier of supplementary food 1-gen-2021 Paolino, D.; Mancuso, A.; Cristiano, M. C.; Froiio, F.; Lammari, N.; Celia, C.; Fresta, M
Paclitaxel-loaded sodium deoxycholate-stabilized zein nanoparticles: characterization and in vitro cytotoxicity 1-gen-2019 Gagliardi, A.; Bonacci, S.; Paolino, D.; Celia, C.; Procopio, A.; Fresta, M.; Cosco, D.
Pegilazione innovativa del killer TNF-apoptosis induced ligand (killer-trail). 1-gen-2019 Celia, C; Cilurzo, F; Cosco, D; Fresta, M; Paolino, D; Sammarco, G; Pasut, G
pH-responsive chitosan based hydrogels affect the release of dapsone: Design, set-up, and physicochemical characterization 1-gen-2019 Chaves, L. L.; Silveri, A.; Vieira, A. C. C.; Ferreira, D.; Cristiano, M. C.; Paolino, D.; Di Marzio, L.; Lima, S. C.; Reis, S.; Sarmento, B.; Celia, C.
Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes 1-gen-2018 Mare, R; Paolino, D; Celia, C; Molinaro, R; Fresta, M; Cosco, D
Pro-drug innovativo micellare su backbone polimerico del Killer TNF-apoptosis induced ligand. 1-gen-2020 Celia, C; Cilurzo, F; Cosco, D; Fresta, M; Paolino, D; Pasut, G
Sistema liposomiale con Killer TNF-apoptosis induced ligand (KillerTRAIL), pro-apoptotico-direzionante 1-gen-2020 Celia, C; Cilurzo, F; Cosco, D; Fresta, M; Paolino, D; Pasut, G
Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting 1-gen-2023 Barone, A.; Zimbo, A. M.; D'Avanzo, N.; Tolomeo, A. M.; Ruga, S.; Cardamone, A.; Celia, C.; Scalise, M.; Torella, D.; La Deda, M.; Iaccino, E.; Paolino, D.